“TYROSINE KINASE INHIBITORS (TKI): TREATMENT OF CHRONIC MIELOIDE LEUKEMIA”, RECIMA21, vol. 3, no. 12, p. e3122405, Dec. 2022, doi: 10.47820/recima21.v3i12.2405.